We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
-6.21%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$148M
AUM Growth
-$12.3M
Cap. Flow
+$11.9M
Cap. Flow %
8.04%
Top 10 Hldgs %
74.02%
Holding
35
New
1
Increased
2
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 68.41%
2 Materials 20.1%
3 Industrials 1.98%
4 Consumer Staples 1.26%
5 Financials 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLT
1
DELISTED
Applied Therapeutics
APLT
$26M 17.54%
5,574,687
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$24.7M 16.62%
710,422
+220,000
+45% +$7.64M
ALDX icon
3
Aldeyra Therapeutics
ALDX
$91.7M
$18.1M 12.21%
5,475,516
AVDL
4
DELISTED
Avadel Pharmaceuticals
AVDL
$8.44M 5.68%
600,000
ALT icon
5
Altimmune
ALT
$539M
$7.46M 5.03%
1,121,524
+554,305
+98% +$4.09M
ENTX icon
6
Entera Bio
ENTX
$101M
$7.14M 4.81%
3,881,879
GLD icon
7
SPDR Gold Trust
GLD
$131B
$6.88M 4.64%
32,000
SILV
8
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$3.83M 2.58%
470,000
KGC icon
9
Kinross Gold
KGC
$28.5B
$3.66M 2.47%
440,000
AEM icon
10
Agnico Eagle Mines
AEM
$72.6B
$3.63M 2.45%
55,500
SA
11
Seabridge Gold
SA
$2.8B
$3.38M 2.27%
246,597
HOOK
12
DELISTED
HOOKIPA Pharma
HOOK
$3.26M 2.2%
551,739
MAG
13
DELISTED
MAG Silver
MAG
$3.21M 2.16%
275,000
WPM icon
14
Wheaton Precious Metals
WPM
$50.6B
$3.15M 2.12%
60,000
FNV icon
15
Franco-Nevada
FNV
$41.4B
$2.96M 2%
25,000
VRNA
16
DELISTED
Verona Pharma
VRNA
$2.89M 1.95%
200,000
EQX icon
17
Equinox Gold
EQX
$7.32B
$2.88M 1.94%
550,811
BAH icon
18
Booz Allen Hamilton
BAH
$8.7B
$2M 1.35%
13,000
SIL icon
19
Global X Silver Miners ETF NEW
SIL
$4.08B
$1.41M 0.95%
45,175
OCUL icon
20
Ocular Therapeutix
OCUL
$1.86B
$1.37M 0.92%
200,400
SLV icon
21
iShares Silver Trust
SLV
$28.1B
$1.29M 0.87%
48,500
V icon
22
Visa
V
$677B
$1.27M 0.86%
4,850
AGI icon
23
Alamos Gold
AGI
$12.4B
$1.25M 0.85%
80,000
PM icon
24
Philip Morris
PM
$301B
$1.01M 0.68%
10,000
ITA icon
25
iShares US Aerospace & Defense ETF
ITA
$14.2B
$1.01M 0.68%
7,650

Similar funds

Knoll Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Knoll Capital Management held 35 positions worth $148M, down 7.7% from $161M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Knoll Capital Management deployed $11.9M of net new capital in Q2 2024, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Cardiol Therapeutics: 100,000 shares worth $202K.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 72% a quarter earlier, followed by Materials and Industrials.

  • Knoll Capital Management's largest Q2 2024 buy was Cardiol Therapeutics: 100,000 shares worth $202K.
  • Knoll Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2024, an estimated $7.64M increase.
  • Knoll Capital Management's ten largest holdings make up 74% of its $148M portfolio in Q2 2024.
  • Knoll Capital Management opened 1 new position and closed 0 in Q2 2024.
  • Knoll Capital Management's portfolio value fell 7.7% quarter-over-quarter to $148M.

Based on Knoll Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.